or
forgot password
  • cancer clinical trials in charleston, SC

  • 1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy
    Charleston Hematology Oncology Associates
    Charleston, South Carolina 29403
    Breast Cancer
    Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Neuroblastoma
    Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer Patients
    Research Site
    Charleston, South Carolina
    Locally Recurrent and Metastatic Breast Cancer
    Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    HER2-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Leukemia
    Patients With Advanced Non-Small Cell Lung Cancer
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Non-Small Cell Lung Carcinoma
    S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Leukemia
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Neuroblastoma
    Learning Impairments Among Survivors of Childhood Cancer
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Acute Lymphoblastic Leukemia, Brain Tumors
    Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Neuroblastoma, Medulloblastoma
    Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    Screening of Bone Mineral Density in Women Who Have Received Chemotherapy
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Bone Density, Cancer
    Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Colorectal Cancer
    Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer
    Research Site
    Charleston, South Carolina
    Metastatic Colorectal Cancer, Colon Cancer, Colorectal Cancer, Rectal Cancer
    Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Hepatic Veno-Occlusive Disease
    AMG 655/Panitumumab Combination Metastatic Colorectal Cancer Study
    Research Site
    Charleston, South Carolina
    Colon Cancer, Colorectal Cancer, Rectal Cancer, Metastatic Colorectal Cancer, Oncology
    Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Lung Cancer
    Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Leukemia
    Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Esophageal Cancer
    Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Kidney Cancer, Leukemia, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Safety Study of Denosumab in Subjects With Recurrent or Unresectable Giant Cell Tumor of Bone
    Research Site
    Charleston, South Carolina
    Cancer, GCT, Giant Cell Tumor of Bone, Benign GCT
    S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer
    Roper St. Francis Cancer Center at Roper Hospital
    Charleston, South Carolina 29401
    Colorectal Cancer
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Roper Hospital
    Charleston, South Carolina 29401
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer
    Hollings Cancer Center
    Charleston, South Carolina 29403
    Thyroid Cancer
    Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Secondary Acute Myeloid Leukemia (Secondary AML, sAML)
    Inflammation and Treatment of Bacterial Vaginosis Near Term
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Bacterial Vaginosis
    Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Brain and Central Nervous System Tumors
    BIBW 2992 (Afatinib) With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant Glioma
    1200.36.0007 Boehringer Ingelheim Investigational Site
    Charleston, South Carolina
    Glioma
    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
    A Phase II Study of AS1411 in Renal Cell Carcinoma
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Metastatic Renal Cell Carcinoma
    Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
    Charleston Hematology Oncology Associates, PA
    Charleston, South Carolina 29403
    Multiple Myeloma and Plasma Cell Neoplasm
    Evaluating the Safety and Effectiveness of Bone Marrow Transplants in Children With Sickle Cell Disease (BMT CTN #0601) (The SCURT Study)
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Sickle Cell Disease
    Airway Epithelium Gene Expression: AEGIS II
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Lung Cancer
    Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By Surgery
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Kidney Cancer
    Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Graft vs Host Disease, Graft-Versus-Host Disease
    Efficacy and Safety Study of OncoVEXGM-CSF Compared to GM-CSF in Melanoma
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Melanoma
    A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Breast Cancer
    S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    Determining Predictors of Safe Discontinuation of Anti-TNF Treatment in JIA
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Juvenile Idiopathic Arthritis
    Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia, L1 Adult Acute Lymphoblastic Leukemia, L2 Adult Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, T-cell Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    PEAK: A Phase 2 Study of Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer Subjects With Wild-Type KRAS Tumors
    Research Site
    Charleston, South Carolina
    Colon Cancer, Colorectal Cancer, Rectal Cancer, Metastatic Colorectal Cancer
    Salvage Cryotherapy in Recurrent Prostate Cancer
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Recurrent Prostate Cancer
    Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Rheumatoid Arthritis
    Evaluating the Safety and Effectiveness of a Bone Marrow Transplant From Partially Matched Donors and Using Low Dose Chemotherapy in People With Leukemia or Lymphoma (BMT CTN #0603)
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse
    Efficacy and Safety of MORAb-003 in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Ovarian Cancer
    Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer
    Charleston Hematology Oncology Associates, PA
    Charleston, South Carolina 29403
    Non-small Cell Lung Cancer (NSCLC)
    Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
    Research Site
    Charleston, South Carolina
    Non-Small Cell Lung Cancer, Anemia, Cancer, Lung Cancer
    Safety and Efficacy Study of Thymoglobulin Versus IL2 Receptor Antagonists
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    End Stage Renal Disease
    Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    High-grade Salivary Gland Mucoepidermoid Carcinoma, Low-grade Salivary Gland Mucoepidermoid Carcinoma, Recurrent Salivary Gland Cancer, Salivary Gland Acinic Cell Tumor, Salivary Gland Adenocarcinoma, Salivary Gland Adenoid Cystic Carcinoma, Salivary Gland Anaplastic Carcinoma, Salivary Gland Malignant Mixed Cell Type Tumor, Salivary Gland Poorly Differentiated Carcinoma, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer
    Study of Immunotherapy to Treat Advanced Prostate Cancer
    MUSC Hollings Cancer Center
    Charleston, South Carolina 29425
    Prostate Cancer
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    Roper Hospital
    Charleston, South Carolina 29401
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant That Uses Low Dose Chemotherapy in People With Leukemia or Lymphoma (BMT CTN #0604)
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse
    Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Neuroblastoma, Medulloblastoma, Relapse
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Roper St. Francis Cancer Center at Roper Hospital
    Charleston, South Carolina 29401
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Leukemia, Lymphoma
    S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Plasma Cell Neoplasm, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific